HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Ikejiri Selected Research

factor IX Cambridge

1/2019Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Ikejiri Research Topics

Disease

5Thrombosis (Thrombus)
09/2017 - 09/2010
4Neoplasms (Cancer)
01/2022 - 09/2010
4Hemophilia A (Haemophilia)
01/2019 - 07/2018
4Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2017 - 03/2012
3Infections
10/2021 - 01/2019
3Thrombotic Thrombocytopenic Purpura
06/2019 - 05/2009
3Thrombotic Microangiopathies
06/2019 - 05/2009
3Disseminated Intravascular Coagulation
01/2019 - 03/2014
3Thrombophilia
03/2017 - 03/2012
3Venous Thrombosis (Deep-Vein Thrombosis)
05/2016 - 09/2010
2Ciliary Motility Disorders (Primary Ciliary Dyskinesia)
04/2022 - 07/2021
2Cytomegalovirus Infections (Inclusion Disease)
10/2021 - 07/2021
2Hemorrhage
01/2019 - 01/2019
2Connective Tissue Diseases (Connective Tissue Disease)
09/2017 - 01/2016
2Venous Thromboembolism
03/2017 - 01/2017
1Cystic Fibrosis (Mucoviscidosis)
05/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Hypokalemia
11/2020
1Acute Kidney Injury (Acute Renal Failure)
11/2020
1Hypoalbuminemia
11/2020
1Adenocarcinoma
04/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2020
1Hematologic Diseases (Blood Diseases)
06/2019
1Hemolytic-Uremic Syndrome
06/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Hemolysis
11/2018
1Spontaneous Abortion (Miscarriage)
01/2017
1hereditary Thrombophilia
01/2017
1Protein C Deficiency
01/2017
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2016
1Atypical Hemolytic Uremic Syndrome
11/2014
1Splenic Infarction
01/2014
1Flaujeac factor deficiency
01/2014
1Vitamin K Deficiency
06/2013
1Hepatocellular Carcinoma (Hepatoma)
06/2013
1Obstructive Jaundice (Cholestatic Jaundice)
06/2013
1Pulmonary Embolism
06/2010
1Thromboembolism
06/2010
1Sepsis (Septicemia)
06/2009
1Bacteremia
06/2009
1Bacterial Infections (Bacterial Infection)
06/2009
1Thrombocytopenia (Thrombopenia)
05/2009

Drug/Important Bio-Agent (IBA)

6Protein SIBA
03/2017 - 06/2010
5AntithrombinsIBA
03/2017 - 03/2012
4Dacarbazine (DIC)FDA LinkGeneric
06/2019 - 03/2014
3AntibodiesIBA
10/2021 - 06/2013
3Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2017
3Hemostatics (Antihemorrhagics)IBA
01/2019 - 09/2015
3Fibrinogen (Factor I)FDA Link
01/2019 - 01/2017
3Protein CIBA
03/2017 - 03/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2009
2Biomarkers (Surrogate Marker)IBA
04/2020 - 06/2013
2Warfarin (Coumadin)FDA LinkGeneric
01/2019 - 06/2013
2FibrinIBA
10/2018 - 07/2018
2thiamine triphosphorate (TTP)IBA
09/2017 - 05/2009
2Antiphospholipid AntibodiesIBA
01/2016 - 03/2013
2protein S TokushimaIBA
01/2012 - 09/2010
1rho-Associated KinasesIBA
05/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2022
1Immunoglobulin G (IgG)IBA
07/2021
1cytomegalovirus-specific hyperimmune globulinIBA
07/2021
1Immunoglobulin M (IgM)IBA
07/2021
1pembrolizumabIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
11/2020
1Culture MediaIBA
04/2020
1CarbohydratesIBA
04/2020
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
04/2020
1C-Type Lectins (C-Type Lectin)IBA
06/2019
1factor IX CambridgeIBA
01/2019
1AnticoagulantsIBA
01/2019
1eculizumabFDA Link
11/2018
1BilirubinIBA
11/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2018
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
10/2018
1Factor VIII (Coagulation Factor VIII)IBA
07/2018
1von Willebrand FactorIBA
09/2017
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
09/2017
1edoxabanIBA
01/2017
1Fondaparinux (Arixtra)FDA Link
05/2016
1Inosine Triphosphate (ITP)IBA
01/2016
1AntigensIBA
09/2015
1Complement System Proteins (Complement)IBA
11/2014
1platelet membrane glycoprotein VIIBA
03/2014
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
01/2014
1Tumor Biomarkers (Tumor Markers)IBA
06/2013
1Prothrombin (Factor II)IBA
06/2013
1P 11 (P-11)IBA
06/2013
1Fetal Proteins (Fetoprotein)IBA
06/2013
1ProcalcitoninIBA
06/2009

Therapy/Procedure

1Therapeutics
01/2021
1Orthopedic Procedures
01/2017
1Bed Rest (Bedrest)
09/2010
1Critical Care (Surgical Intensive Care)
06/2009